LISATA THERAPEUTICS, INC. Accounts Receivable
LISATA THERAPEUTICS, INC. (LSTA) had Accounts Receivable of $0 as of 2025-12-31, per its 10-K filed 2026-03-12.
Financial Statements › Balance Sheet › Assets › Assets, Current
us-gaap:AccountsReceivableNetCurrent · last filed 2026-03-12
- 2025-12-31: Accounts Receivable, after Allowance for Credit Loss, Current $0.00.
- 2024-12-31: Accounts Receivable, after Allowance for Credit Loss, Current $900.00K.
- 2023-12-31: Accounts Receivable, after Allowance for Credit Loss, Current $0.00.
- 2018-03-31: Accounts Receivable, after Allowance for Credit Loss, Current $144.26K.
| Period end | Accounts Receivable, after Allowance for Credit Loss, Current | Accounts Receivable, after Allowance for Credit Loss, Current as first filed |
|---|---|---|
| 2025-12-31 | $0.00 10-K · filed 2026-03-12 | |
| 2024-12-31 | $900.00K 10-K · filed 2026-03-12 | |
| 2023-12-31 | $0.00 10-K · filed 2025-02-27 | |
| 2018-03-31 | $144.26K 10-Q · filed 2018-05-10 | |
| 2017-12-31 | $234.46K 10-Q · filed 2018-05-10 | |
| 2017-09-30 | $401.56K 10-Q · filed 2017-11-09 | |
| 2017-06-30 | $335.65K 10-Q · filed 2017-08-10 | |
| 2017-03-31 | $3.17M 10-Q · filed 2017-05-15 | |
| 2016-12-31 | $138.77K 10-K · filed 2018-03-22 | $2.89M 10-K · filed 2017-03-17 |
| 2016-09-30 | $4.27M 10-Q · filed 2016-11-07 | |
| 2016-06-30 | $2.89M 10-Q · filed 2016-08-09 | |
| 2016-03-31 | $2.61M 10-Q · filed 2016-05-05 | |
| 2015-12-31 | $2.57M 10-K · filed 2017-03-17 | |
| 2015-09-30 | $2.30M 10-Q · filed 2015-11-05 | |
| 2015-06-30 | $1.30M 10-Q · filed 2015-08-06 | |
| 2015-03-31 | $1.97M 10-Q · filed 2015-05-06 | |
| 2014-12-31 | $3.11M 10-K · filed 2016-03-15 | |
| 2014-09-30 | $2.09M 10-Q · filed 2014-10-30 | |
| 2014-06-30 | $2.51M 10-Q · filed 2014-08-07 | |
| 2014-03-31 | $1.89M 10-Q · filed 2014-05-08 | |
| 2013-12-31 | $1.86M 10-K · filed 2015-03-02 | |
| 2013-09-30 | $1.39M 10-Q · filed 2013-11-07 | |
| 2013-06-30 | $701.62K 10-Q · filed 2013-08-08 | |
| 2013-03-31 | $886.16K 10-Q · filed 2013-05-09 | |
| 2012-12-31 | $1.05M 10-K · filed 2014-03-13 | |
| 2012-09-30 | $1.79M 10-Q · filed 2012-11-13 | |
| 2012-06-30 | $1.26M 10-Q · filed 2012-08-14 | |
| 2012-03-31 | $10.44M 10-Q · filed 2012-05-11 | |
| 2011-12-31 | $1.01M 10-K · filed 2013-03-11 | $6.54M 10-K · filed 2012-03-20 |
| 2011-09-30 | $8.94M 10-Q · filed 2011-11-10 | |
| 2011-06-30 | $7.35M 10-Q · filed 2011-08-12 | |
| 2010-12-31 | $28.21K 8-K · filed 2012-08-15 | $5.87M 10-Q · filed 2011-08-12 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Vistagen Therapeutics, Inc. (VTGN) | United States | $0.013B | -0.14 |
| MUSTANG BIO, INC. (MBIO) | United States | $0.013B | |
| BullFrog AI Holdings, Inc. (BFRG) | United States | $0.014B | |
| AEON Biopharma, Inc. (AEON) | United States | $0.013B | -0.36 |
| Vyome Holdings, Inc (HIND) | United States | $0.014B | -1.38 |
| Tvardi Therapeutics, Inc. (TVRD) | United States | $0.014B | |
| Tempest Therapeutics, Inc. (TPST) | United States | $0.013B | |
| Aspire Biopharma Holdings, Inc. (ASBP) | United States | $0.012B | -0.60 |
| ACTUATE THERAPEUTICS, INC. (ACTU) | United States | $0.015B | |
| BIOVIE INC. (BIVI) | United States | $0.012B |